EUVIMEDEUVIMED entdecken
Open Access

In vitro and in vivo efficacy of the amiodarone and praziquantel combination against the blood fluke Schistosoma mansoni

Rayssa A Cajas, Silvia S B Santos, Maria Cristina C Espírito-Santo, Yagoob Garedaghi iD, Josué de Moraes iD

Antimicrobial Agents and Chemotherapy · 2024

DOI: 10.1128/aac.00114-24 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Antimicrobial Agents and Chemotherapy, 2024. Verfasst von Rayssa A Cajas und 4 weiteren Autor:innen. Beteiligte Einrichtung: Research Center on Neglected Diseases, Guarulhos University, São Paulo, Brazil. Hauptthemen laut MEDLINE: Amiodarone, Praziquantel, Schistosoma mansoni, Schistosomiasis mansoni. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP), Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq), Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Schistosomiasis, a widespread parasitic disease caused by the blood fluke of the genus Schistosoma , affects over 230 million people, primarily in developing countries. Praziquantel, the sole drug currently approved for schistosomiasis treatment, demonstrates effectiveness against patent infections. A recent study highlighted the antiparasitic properties of amiodarone, an anti-arrhythmic drug, exhibiting higher efficacy than praziquantel against prepatent infections. This study assessed the efficacy of amiodarone and praziquantel, both individually and in combination, against Schistosoma mansoni through comprehensive in vitro and in vivo experiments. In vitro experiments demonstrated synergistic activity (fractional inhibitory concentration index ≤0.5) for combinations of amiodarone with praziquantel. In a murine model of schistosomiasis featuring prepatent infections, treatments involving amiodarone (200 or 400 mg/kg) followed by praziquantel (200 or 400 mg/kg) yielded a substantial reduction in worm burden (60%–70%). Given the low efficacy of praziquantel in prepatent infections, combinations of amiodarone with praziquantel may offer clinical utility in the treatment of schistosomiasis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AmiodaronePraziquantelSchistosoma mansoniSchistosomiasis mansoniAnimalsMiceFemaleAnthelminticsDrug SynergismDrug Therapy, CombinationMaleDisease Models, Animal

Stichwörter der Autor:innen

antiparasitic agentsantischistosomal drugdrug combinationschistosomiasis

Substanzen

AmiodaronePraziquantelAnthelmintics

Autor:innen und Institutionen

  • Research Center on Neglected Diseases, Guarulhos University, São Paulo, Brazil.
  • Department of Infectious and Parasitic Diseases, Faculty of Medicine, Laboratory of Immunopathology of Schistosomiasis (LIM-06), University of São Paulo, São Paulo, Brazil.
  • Laboratory of Helminthology, Institute of Tropical Medicine, University of São Paulo, São Paulo, Brazil.
  • Department of Parasitology, Faculty of Veterinary Medicine, Tabriz Medical Sciences, Islamic Azad University, Tabriz, Iran.
  • Research Center on Neglected Diseases, Scientific and Technological Institute, Brazil University, São Paulo, Brazil.

ORCID-Profile: Yagoob Garedaghi, Josué de Moraes

Förderung

  • Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)
  • Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq)
  • Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES)

Zitieren

APA

Cajas, R. A., Santos, S. S. B., Espírito-Santo, M. C. C., Garedaghi, Y., & de Moraes, J. (2024). In vitro and in vivo efficacy of the amiodarone and praziquantel combination against the blood fluke Schistosoma mansoni. Antimicrobial Agents and Chemotherapy. https://doi.org/10.1128/aac.00114-24

Vancouver

Cajas RA, Santos SSB, Espírito-Santo MCC, Garedaghi Y, de Moraes J. In vitro and in vivo efficacy of the amiodarone and praziquantel combination against the blood fluke Schistosoma mansoni. Antimicrobial Agents and Chemotherapy. 2024. doi:10.1128/aac.00114-24

BibTeX
@article{Cajas2024,
  author = {Cajas, Rayssa A and Santos, Silvia S B and Espírito-Santo, Maria Cristina C and Garedaghi, Yagoob and de Moraes, Josué},
  title = {In vitro and in vivo efficacy of the amiodarone and praziquantel combination against the blood fluke Schistosoma mansoni},
  journal = {Antimicrobial Agents and Chemotherapy},
  year = {2024},
  doi = {10.1128/aac.00114-24}
}
Kostenlos starten →